SCHEMBL8900988

SCHEMBL8900988

CC(Oc1ccc(Oc2ccc(Oc3ccc(OC(C)C(=O)O)cc3)cc2)cc1)C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.69
GAA P10253 1/20 0.69
CYP2C9 P11712 1/20 0.69
PKM P14618 1/20 0.69
CYP2C19 P33261 1/20 0.69
TDP1 Q9NUW8 1/20 0.63
PPARG P37231 4/20 0.53
PPARA Q07869 4/20 0.53
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TBXAS1 P24557 2/20 0.49
KMT2A Q03164 2/20 0.48
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
TAS1R2 Q8TE23 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
POLB P06746 1/20 0.47
APOBEC3A P31941 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11550164 1.00 CYP1A2 (0.69) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL9362383 0.94 CYP1A2 (0.73) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL9656870 0.94 CYP1A2 (0.73) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL4262556 0.93 CYP1A2 (0.77) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL24805728 0.92 CYP1A2 (0.61) CYP1A2GAACYP2C9PKMCYP2C19
Hydrochloric Acid SCHEMBL9366029 0.92 CYP1A2 (0.71) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL21992740 0.92 CYP1A2 (0.61) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL11180474 0.92 CYP1A2 (0.61) CYP1A2GAACYP2C9PKMCYP2C19
Hydrochloric Acid SCHEMBL9362752 0.92 CYP1A2 (0.71) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL11154253 0.91 CYP1A2 (0.59) CYP1A2GAACYP2C9PKMCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0663391-B1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls HOFFMANN LA ROCHE (CH) 1997-04-09 EP disclosed
US-5521160-A COMPOUNDS FOR TREATMENT OF ATHERIOSCLEROSIS IN BLOOD VESSELS AND PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY HOFFMANN-LA ROCHE INC. (US) 1996-05-28 US disclosed
EP-0663391-A1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls F. HOFFMANN-LA ROCHE AG (CH) 1995-07-19 EP disclosed